BackgroundA quarter of the population will die of cancer. New approaches are needed. Approaches that activate the body's immune system to fight cancer are particularly attractive.
Our ApproachWe have developed over 20 new molecular tools that activate the immune system to fight cancer. These molecules switch on a novel pathway that cancer cells are thought to suppress to evade the immune system.
Potential ImpactWhen successful, these molecular tools will establish first-in-class therapeutics effective across multiple cancer indications.
StatusPreclinical.
biOOrg3.14 is actively seeking investment and strategic partnerships to accelerate clinical development of BG-200A.